Ascentage Pharma Group International (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

15.06

-0.25 (-1.63%)

At close: Oct 13, 2026, 4:00 PM EDT

15.06

0.00 (0.00%)

After-hours: Oct 13, 2026, 4:10 PM EDT

AAPG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,350	2,471	1,812	995	851	932
Market Cap Growth	-60.61%	36.38%	82.10%	16.89%	-8.64%	-15.02%
Enterprise Value	1,381	2,480	1,896	1,009	830	798
Last Close Price	15.31	26.24	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	14.51	30.10	13.48	31.78	27.99	212.05
PB Ratio	16.48	12.95	48.23	99.87	14.36	4.79
P/TBV Ratio	18.87	14.01	80.87	-	19.59	5.15

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	14.84	30.21	14.11	32.24	27.31	181.70

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	3.70	1.48	6.09	25.42	4.39	0.88
Net Debt / Equity Ratio	0.35	-0.37	1.47	9.84	0.71	-0.54
Net Debt / EBITDA Ratio	-0.15	0.43	-1.34	-0.85	-0.34	0.73
Net Debt / FCF Ratio	-0.15	0.41	-2.96	-0.90	-0.34	0.64
Asset Turnover	0.20	0.17	0.38	0.08	0.07	0.01
Inventory Turnover	1.07	2.78	2.56	2.38	3.29	-
Quick Ratio	1.09	1.69	1.17	1.35	1.78	5.05
Current Ratio	1.22	1.79	1.26	1.44	1.86	5.22
Return on Equity (ROE)	-236.63%	-154.56%	-235.32%	-386.28%	-107.45%	-75.18%
Return on Assets (ROA)	-28.04%	-23.02%	-9.25%	-20.92%	-19.14%	-24.97%
Return on Capital Employed (ROCE)	-103.90%	-52.20%	-26.10%	-57.00%	-45.30%	-36.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-15.75%	-7.19%	-3.07%	-13.12%	-15.04%	-13.22%
FCF Yield	-14.61%	-6.95%	-1.03%	-10.95%	-14.60%	-17.57%
Buyback Yield / Dilution	-13.76%	-17.90%	-7.00%	-7.07%	-3.56%	-17.93%

SEC Filings: 10-K · 10-Q